Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/1/24 16:01 | 3/28/24 | GANX | Health | Drug | Pharmaceutical Preparations | Riley Jeffrey Scott | MD | D | P | 116 | 3.86 | 0 | 30 | New | 30 | D | |||||||||||||||
5/27/22 16:10 | 5/25/22 | GANX | Health | Drug | Pharmaceutical Preparations | Richman Eric I | MD | DO | CEO | P | 6 | 2.58 | 0 | 2 | 1 | 233 | D | ||||||||||||||
5/23/22 16:41 | 5/19/22 | GANX | Health | Drug | Pharmaceutical Preparations | Richman Eric I | MD | DO | CEO | P.m | 37 | 2.79 | 0 | 13 | 6 | 230 | D | ||||||||||||||
5/23/22 16:00 | 5/19/22 | GANX | Health | Drug | Pharmaceutical Preparations | Calabrese Salvatore | MD | O | CFO | P.a | 8 | 2.70 | 0 | 3 | New | 3 | D | ||||||||||||||
5/19/22 17:00 | 5/19/22 | GANX | Health | Drug | Pharmaceutical Preparations | Calabrese Salvatore | MD | O | CFO | P.e | 8 | 2.70 | 0 | 3 | 0 | D | |||||||||||||||
4/21/22 16:50 | 8/16/21 | GANX | Health | Drug | Pharmaceutical Preparations | Richman Eric I | MD | DO | CEO | P.a | 39 | 7.87 | 0 | 5 | 2 | 217 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |